MedPath

DEXCOM, INC.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

30

Active:0
Completed:23

Trial Phases

1 Phases

Not Applicable:12

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (12 trials with phase data)• Click on a phase to view related trials

Not Applicable
12 (100.0%)

Dexcom Continuous Glucose Monitoring System Use in aReal-World, Global Registry (Dexcom Global Registry)

Recruiting
Conditions
Diabetes
First Posted Date
2024-07-03
Last Posted Date
2024-07-03
Lead Sponsor
DexCom, Inc.
Target Recruit Count
5000
Registration Number
NCT06483945
Locations
🇺🇸

Institute of Endocrinology Diabetes, Health & Hormones, Stockbridge, Georgia, United States

🇺🇸

Palm Research Center, Las Vegas, Nevada, United States

Performance of the Dexcom Continuous Glucose Monitoring (CGM) System in Pregnant Women With Diabetes Mellitus

Conditions
Diabetes Mellitus
First Posted Date
2021-05-27
Last Posted Date
2022-02-21
Lead Sponsor
DexCom, Inc.
Target Recruit Count
100
Registration Number
NCT04905628
Locations
🇺🇸

Sansum Diabetes Research Institute, Santa Barbara, California, United States

🇺🇸

Barbara Davis Center for Childhood Diabetes, Aurora, Colorado, United States

🇺🇸

Joslin Diabetes Center, Boston, Massachusetts, United States

and more 2 locations

Effectiveness and Safety of the Dexcom G6 Continuous Glucose Monitoring System in Non-Critically Ill Patients in the Inpatient Setting

Not Applicable
Conditions
Patients Needing Glucose Control
First Posted Date
2021-05-10
Last Posted Date
2021-05-10
Lead Sponsor
DexCom, Inc.
Target Recruit Count
250
Registration Number
NCT04879693

Evaluation of Modified Adhesives With Dexcom G6 Sensor

Completed
Conditions
Diabetes
First Posted Date
2021-04-12
Last Posted Date
2021-04-12
Lead Sponsor
DexCom, Inc.
Target Recruit Count
80
Registration Number
NCT04840446
Locations
🇺🇸

Jaeb Center for Health Research, Tampa, Florida, United States

Evaluation of the Safety and Effectiveness of the Dexcom Continuous Glucose Monitoring (CGM) System

Not Applicable
Completed
Conditions
Diabetes Mellitus
First Posted Date
2021-03-12
Last Posted Date
2022-02-18
Lead Sponsor
DexCom, Inc.
Target Recruit Count
482
Registration Number
NCT04794478
Locations
🇺🇸

ProSciento, Chula Vista, California, United States

🇺🇸

AMCR Institute, Escondido, California, United States

🇺🇸

Sansum Diabetes Research Institute, Santa Barbara, California, United States

and more 9 locations
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.